Advertisement

Pharmacy

Seeking to reduce costs, retail giant Walmart plans to eliminate some jobs in its U.S. pharmacy business, Bloomberg reports. 

Advertisement

Five drug categories, including shortages of controlled substances, have affected hospitals the most in terms of cost and reallocation of resources, according to a new survey from Vizient.

Patent tactics preventing biosimilars from entering the market have cost the U.S. healthcare system $7.6 billion since 2015, according to a new whitepaper published by the Association for Accessible Medication's Biosimilars Council. 

Advertisement